Home LiteratureArticle Details
PMID: 19075244 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection.

Brooks DG, Ha SJ, Elsaesser H, Sharpe AH, Freeman GJ, Oldstone MB

Abstract

Suppression of T-cell responses by host-derived regulatory factors is a key event leading to viral persistence. Antibody blockade of either IL-10 or programmed death-ligand 1 (PD-L1) during viral persistence enhances T-cell function and reduces viral titers. Because blockade of these immunoregulatory networks represents a powerful approach to establish immune control during persistent infection, it is important to determine whether these immunoinhibitory factors act independently or jointly and if combined blockade of these factors further enhances T-cell immunity and viral clearance. Herein, we demonstrate that the IL-10 and PD-L1 immunosuppressive pathways are mechanistically distinct. As a result, simultaneous blockade of IL-10 and PD-L1 was significantly more effective in restoring antiviral T-cell responses than blockade of either alone, and led to substantially enhanced control of an established persistent viral infection. Thus, combinatorial blockade of multiple immune-regulatory molecules may ultimately restore the T-cell responses required to tip the balance from viral persistence to immune-mediated control or elimination of persistent infection.

MeSH Terms
Animals Antibodies/pharmacology,therapeutic use Antigens, CD/drug effects,physiology B7-H1 Antigen Drug Therapy, Combination Immunity/drug effects Immunotherapy/methods Interleukin-10/antagonists & inhibitors,physiology Mice Mice, Inbred C57BL Signal Transduction/immunology T-Lymphocytes/drug effects,immunology Virus Diseases/immunology,therapy
Chemicals
Antibodies Antigens, CD B7-H1 Antigen CD274 protein, human Interleukin-10
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Brooks David G
Department of Microbiology, Immunology and Molecular Genetics, and the UCLA AIDS Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles CA 90095, USA. dbrooks@em.ucla.edu
Ha Sang-Jun
Elsaesser Heidi
Sharpe Arlene H
Freeman Gordon J
Oldstone Michael B A
References (36)
36 references, click to expand
  1. Restoring function in exhausted CD8 T cells during chronic viral infection.
    Nature. 2006 Feb 9;439(7077):682-7 PMID: 16382236
  2. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.
    Gut. 2006 Jul;55(7):1012-9 PMID: 16484505
  3. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    J Virol. 1994 Dec;68(12):8056-63 PMID: 7966595
  4. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection.
    J Exp Med. 2008 Mar 17;205(3):533-41 PMID: 18332180
  5. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion.
    J Virol. 2006 Nov;80(22):11398-403 PMID: 16956940
  6. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.
    Immunity. 1999 Aug;11(2):141-51 PMID: 10485649
  7. IL-10, T cell exhaustion and viral persistence.
    Trends Microbiol. 2007 Apr;15(4):143-6 PMID: 17336072
  8. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Eur J Immunol. 1998 Jan;28(1):390-400 PMID: 9485218
  9. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy.
    J Virol. 2008 Apr;82(7):3391-404 PMID: 18199637
  10. Elimination of chronic viral infection by blocking CD27 signaling.
    J Exp Med. 2006 Sep 4;203(9):2145-55 PMID: 16923852
  11. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.
    J Virol. 2003 Apr;77(8):4911-27 PMID: 12663797
  12. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha.
    Blood. 2004 Jul 15;104(2):487-94 PMID: 15059848
  13. Determinants of viral clearance and persistence during acute hepatitis C virus infection.
    J Exp Med. 2001 Nov 19;194(10):1395-406 PMID: 11714747
  14. Initial T cell frequency dictates memory CD8+ T cell lineage commitment.
    Nat Immunol. 2005 Aug;6(8):793-9 PMID: 16025119
  15. Viral persistence.
    Cell. 1989 Feb 24;56(4):517-20 PMID: 2645053
  16. Cellular immunotherapy for viral infection after HSC transplantation.
    Nat Rev Immunol. 2005 Jan;5(1):9-20 PMID: 15630425
  17. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.
    J Virol. 2007 Mar;81(6):2545-53 PMID: 17182670
  18. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.
    Science. 2001 Jan 12;291(5502):319-22 PMID: 11209085
  19. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression.
    J Virol. 1995 Feb;69(2):1059-70 PMID: 7815484
  20. Resolution of a chronic viral infection after interleukin-10 receptor blockade.
    J Exp Med. 2006 Oct 30;203(11):2461-72 PMID: 17030951
  21. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis.
    Eur J Immunol. 2003 Nov;33(11):3117-26 PMID: 14579280
  22. PD-1 and its ligands in tolerance and immunity.
    Annu Rev Immunol. 2008;26:677-704 PMID: 18173375
  23. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection.
    J Clin Invest. 2006 Jun;116(6):1675-85 PMID: 16710479
  24. Viral immune evasion due to persistence of activated T cells without effector function.
    J Exp Med. 1998 Dec 21;188(12):2205-13 PMID: 9858507
  25. Defining parameters for successful immunocytotherapy of persistent viral infection.
    Virology. 2000 Jan 20;266(2):257-63 PMID: 10639312
  26. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
    Immunity. 2007 Jul;27(1):111-22 PMID: 17629517
  27. Interleukin-10 determines viral clearance or persistence in vivo.
    Nat Med. 2006 Nov;12(11):1301-9 PMID: 17041596
  28. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.
    J Exp Med. 1998 May 4;187(9):1383-93 PMID: 9565631
  29. Interleukin-10-deficient mice develop chronic enterocolitis.
    Cell. 1993 Oct 22;75(2):263-74 PMID: 8402911
  30. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.
    Nature. 1986 May 15-21;321(6067):239-43 PMID: 3086743
  31. Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus.
    Clin Immunol. 2005 Oct;117(1):57-64 PMID: 16006191
  32. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection.
    J Exp Med. 2008 Mar 17;205(3):543-55 PMID: 18332181
  33. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.
    J Exp Med. 2007 Oct 1;204(10):2473-85 PMID: 17893201
  34. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.
    J Virol. 1994 Jul;68(7):4700-4 PMID: 7911534
  35. Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells.
    J Virol. 2008 Oct;82(20):10017-31 PMID: 18667516
  36. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.
    Blood. 2006 Jun 15;107(12):4781-9 PMID: 16467198
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2008-12-23
Epub
2008-00-15
Pages
20428-33
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2629263
Subset
IM
Grants
NIAID NIH HHS · P01 AI056299 · United States
NIAID NIH HHS · R01 AI045927 · United States
NIAID NIH HHS · R37 AI038310 · United States
NIAID NIH HHS · R21 AI077012 · United States
NIAID NIH HHS · R01 AI009484 · United States
NIAID NIH HHS · AI045927 · United States
NIAID NIH HHS · AI077012 · United States
NIAID NIH HHS · AI009484 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com